NCI - Funding Opportunity Announcement (FOA): Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional)
|Thread Post Created on Tue, February 23, 2021 10:27 AM|
NCI is pleased to announce the publication of a new NCI funding opportunity announcement (FOA): Cancer Prevention, Detection, Diagnosis, and Treatment Technologies for Global Health (U01 Clinical Trial Optional).
NCI will host an informational webinar for potential applicants on Friday, March 12th from 9:00 AM to 10:30 AM Eastern Time. NCI program staff will present on the scope and focus of the program and take questions from interested potential applicants.
Open Date: May 02, 2021
Expiration Date: June 03, 2021
This new FOA supports the development of cancer-relevant technologies suitable for use in low- and middle-income countries (LMICs). Specifically, the FOA solicits applications for projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting, diagnosing, and/or treating cancers in people living in LMICs.
This funding opportunity is part of a broader NCI-sponsored Affordable Cancer Technologies (ACTs) Program.
Visit the ACTs webpage at for additional program contacts, answers to frequently asked questions, and information on previously funded ACTs awards.